Athanase Innovation AB (OSTO:ATIN) Long-Term Debt: kr0.00 Mil (As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr20.60
View Full Analysis

What is Athanase Innovation AB Long-Term Debt?

Athanase Innovation AB OSTO:ATIN 26 Long-Term Debt is kr0.00 Mil as of Dec. 2020. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

Athanase Innovation AB's Long-Term Debt for the quarter that ended in Dec. 2020 was kr0.00 Mil.

Athanase Innovation AB's quarterly Long-Term Debt declined from Dec. 2019 (kr395.65 Mil) to Jun. 2020 (kr393.60 Mil) and declined from Jun. 2020 (kr393.60 Mil) to Dec. 2020 (kr0.00 Mil).

Athanase Innovation AB's annual Long-Term Debt declined from Jun. 2017 (kr405.90 Mil) to Jun. 2018 (kr401.80 Mil) and declined from Jun. 2018 (kr401.80 Mil) to Jun. 2019 (kr397.70 Mil).

Athanase Innovation AB  (OSTO:ATIN) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Athanase Innovation AB Long-Term Debt Related Terms

Athanase Innovation AB Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB Long-Term Debt Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Long-Term Debt
405.90 401.80 397.70

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Long-Term Debt Get a 7-Day Free Trial 399.75 397.70 395.65 393.60 0.00
OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of kr0.00 Mil mean?
Athanase Innovation AB (OSTO:ATIN) has a Long-Term Debt of kr0.00 Mil as of Dec. 2020.
Is Athanase Innovation AB's Long-Term Debt too high?
Athanase Innovation AB's current Long-Term Debt is kr0.00 Mil. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's Long-Term Debt compare to EVG and SMM?
Athanase Innovation AB's Long-Term Debt of kr0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for an Asset Management company?
A good Long-Term Debt depends on the Asset Management industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Athanase Innovation AB's current Long-Term Debt is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current Long-Term Debt of kr0.00 Mil. The current Long-Term Debt is kr0.00 Mil. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current Long-Term Debt is kr0.00 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.60
Price